| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 7.82e-05 | 9 | 31 | 2 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 9.76e-05 | 10 | 31 | 2 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.69e-04 | 13 | 31 | 2 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.97e-04 | 14 | 31 | 2 | GO:1903299 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 5.93e-05 | 8 | 31 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 9.51e-05 | 10 | 31 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 1.92e-04 | 14 | 31 | 2 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 3.21e-04 | 18 | 31 | 2 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 3.98e-04 | 20 | 31 | 2 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 4.39e-04 | 21 | 31 | 2 | GO:0106068 | |
| Domain | Ran_BP1 | 1.63e-04 | 12 | 30 | 2 | PF00638 | |
| Domain | TIL | 1.63e-04 | 12 | 30 | 2 | PF01826 | |
| Domain | C8 | 1.63e-04 | 12 | 30 | 2 | PF08742 | |
| Domain | RANBD1 | 1.63e-04 | 12 | 30 | 2 | PS50196 | |
| Domain | Unchr_dom_Cys-rich | 1.92e-04 | 13 | 30 | 2 | IPR014853 | |
| Domain | RanBD | 1.92e-04 | 13 | 30 | 2 | SM00160 | |
| Domain | C8 | 1.92e-04 | 13 | 30 | 2 | SM00832 | |
| Domain | Ran_bind_dom | 1.92e-04 | 13 | 30 | 2 | IPR000156 | |
| Domain | TIL_dom | 2.24e-04 | 14 | 30 | 2 | IPR002919 | |
| Domain | PHD | 2.34e-04 | 75 | 30 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 2.72e-04 | 79 | 30 | 3 | IPR019787 | |
| Domain | VWFD | 2.95e-04 | 16 | 30 | 2 | PS51233 | |
| Domain | VWD | 2.95e-04 | 16 | 30 | 2 | SM00216 | |
| Domain | VWF_type-D | 2.95e-04 | 16 | 30 | 2 | IPR001846 | |
| Domain | VWD | 2.95e-04 | 16 | 30 | 2 | PF00094 | |
| Domain | PHD | 3.87e-04 | 89 | 30 | 3 | SM00249 | |
| Domain | Znf_PHD | 4.13e-04 | 91 | 30 | 3 | IPR001965 | |
| Domain | VWC_out | 4.19e-04 | 19 | 30 | 2 | SM00215 | |
| Domain | ZF_PHD_2 | 4.69e-04 | 95 | 30 | 3 | PS50016 | |
| Domain | ZF_PHD_1 | 4.83e-04 | 96 | 30 | 3 | PS01359 | |
| Domain | Znf_FYVE_PHD | 1.66e-03 | 147 | 30 | 3 | IPR011011 | |
| Domain | VWC | 1.69e-03 | 38 | 30 | 2 | SM00214 | |
| Domain | VWF_dom | 2.06e-03 | 42 | 30 | 2 | IPR001007 | |
| Domain | SAM_2 | 2.16e-03 | 43 | 30 | 2 | PF07647 | |
| Domain | C1_1 | 3.77e-03 | 57 | 30 | 2 | PF00130 | |
| Domain | ZF_DAG_PE_1 | 4.73e-03 | 64 | 30 | 2 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 4.73e-03 | 64 | 30 | 2 | PS50081 | |
| Domain | Zinc_finger_PHD-type_CS | 4.87e-03 | 65 | 30 | 2 | IPR019786 | |
| Domain | C1 | 4.87e-03 | 65 | 30 | 2 | SM00109 | |
| Domain | PE/DAG-bd | 5.02e-03 | 66 | 30 | 2 | IPR002219 | |
| Domain | - | 5.50e-03 | 449 | 30 | 4 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 5.95e-03 | 459 | 30 | 4 | IPR013083 | |
| Domain | EGF_1 | 7.78e-03 | 255 | 30 | 3 | PS00022 | |
| Domain | EGF_2 | 8.64e-03 | 265 | 30 | 3 | PS01186 | |
| Domain | SAM | 8.76e-03 | 88 | 30 | 2 | SM00454 | |
| Domain | Galactose-bd-like | 9.95e-03 | 94 | 30 | 2 | IPR008979 | |
| Domain | SAM_DOMAIN | 1.02e-02 | 95 | 30 | 2 | PS50105 | |
| Domain | SAM | 1.06e-02 | 97 | 30 | 2 | IPR001660 | |
| Pathway | PID_HDAC_CLASSI_PATHWAY | 7.61e-05 | 66 | 18 | 3 | M101 | |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.09e-05 | 150 | 32 | 4 | 28242625 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.18e-05 | 153 | 32 | 4 | 26365490 | |
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.72e-05 | 7 | 32 | 2 | 7559465 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 30944974 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 38838144 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 21205196 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 26632511 | ||
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.72e-05 | 7 | 32 | 2 | 17372272 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 24403063 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 18949001 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 23818861 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 38657106 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.72e-05 | 7 | 32 | 2 | 11353387 | |
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 25187515 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 9037092 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 23536549 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 12191015 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 22821000 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 8603673 | ||
| Pubmed | 1.72e-05 | 7 | 32 | 2 | 20682751 | ||
| Pubmed | 1.90e-05 | 56 | 32 | 3 | 23934736 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 2.29e-05 | 8 | 32 | 2 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 2.29e-05 | 8 | 32 | 2 | 21670213 | |
| Pubmed | Reptilian heart development and the molecular basis of cardiac chamber evolution. | 2.29e-05 | 8 | 32 | 2 | 19727199 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 2.29e-05 | 8 | 32 | 2 | 28745977 | |
| Pubmed | 2.29e-05 | 8 | 32 | 2 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 2.29e-05 | 8 | 32 | 2 | 21310149 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 2.94e-05 | 9 | 32 | 2 | 18394993 | |
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 28877029 | ||
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 11553612 | ||
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 9733766 | ||
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 17887960 | ||
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 10601307 | ||
| Pubmed | 2.94e-05 | 9 | 32 | 2 | 28100513 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 3.67e-05 | 10 | 32 | 2 | 16332688 | |
| Pubmed | 3.67e-05 | 10 | 32 | 2 | 27160050 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 3.67e-05 | 10 | 32 | 2 | 8857542 | |
| Pubmed | 3.67e-05 | 10 | 32 | 2 | 21859863 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 4.49e-05 | 11 | 32 | 2 | 35771867 | |
| Pubmed | Missense Mutation in Human CHD4 Causes Ventricular Noncompaction by Repressing ADAMTS1. | 4.49e-05 | 11 | 32 | 2 | 37254794 | |
| Pubmed | The HAND1 frameshift A126FS mutation does not cause hypoplastic left heart syndrome in mice. | 4.49e-05 | 11 | 32 | 2 | 29016838 | |
| Pubmed | 4.49e-05 | 11 | 32 | 2 | 17069463 | ||
| Pubmed | 4.49e-05 | 11 | 32 | 2 | 34110283 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 4.99e-05 | 736 | 32 | 6 | 29676528 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 6.36e-05 | 13 | 32 | 2 | 31427429 | |
| Pubmed | 7.70e-05 | 486 | 32 | 5 | 20936779 | ||
| Pubmed | 8.55e-05 | 15 | 32 | 2 | 15617677 | ||
| Pubmed | 8.55e-05 | 15 | 32 | 2 | 28732025 | ||
| Pubmed | 8.55e-05 | 15 | 32 | 2 | 14697343 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.09e-04 | 271 | 32 | 4 | 32433965 | |
| Pubmed | 1.24e-04 | 18 | 32 | 2 | 19308021 | ||
| Pubmed | Genome-wide association study link novel loci to endometriosis. | 1.39e-04 | 19 | 32 | 2 | 23472165 | |
| Pubmed | 1.87e-04 | 22 | 32 | 2 | 27717094 | ||
| Pubmed | 1.87e-04 | 22 | 32 | 2 | 38794925 | ||
| Pubmed | A role for Wnt/beta-catenin signaling in lens epithelial differentiation. | 2.43e-04 | 25 | 32 | 2 | 12812787 | |
| Pubmed | 2.60e-04 | 340 | 32 | 4 | 29478914 | ||
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 2.61e-04 | 135 | 32 | 3 | 31077711 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.29e-04 | 146 | 32 | 3 | 23892456 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 3.41e-04 | 1489 | 32 | 7 | 28611215 | |
| Pubmed | 3.51e-04 | 30 | 32 | 2 | 18055048 | ||
| Pubmed | 4.00e-04 | 32 | 32 | 2 | 26142281 | ||
| Pubmed | 4.76e-04 | 399 | 32 | 4 | 37536630 | ||
| Pubmed | 5.07e-04 | 36 | 32 | 2 | 12412008 | ||
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 5.65e-04 | 38 | 32 | 2 | 12791264 | |
| Pubmed | Cdx and T Brachyury Co-activate Growth Signaling in the Embryonic Axial Progenitor Niche. | 6.26e-04 | 40 | 32 | 2 | 28009287 | |
| Pubmed | 6.90e-04 | 42 | 32 | 2 | 34244791 | ||
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | 6.98e-04 | 442 | 32 | 4 | 15815621 | |
| Pubmed | 7.41e-04 | 193 | 32 | 3 | 22589738 | ||
| Pubmed | Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis. | 8.64e-04 | 47 | 32 | 2 | 28813421 | |
| Pubmed | 8.64e-04 | 47 | 32 | 2 | 18351675 | ||
| Cytoband | 2q24.2 | 1.08e-04 | 22 | 32 | 2 | 2q24.2 | |
| Cytoband | 19q13.1 | 6.83e-04 | 55 | 32 | 2 | 19q13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q24 | 3.57e-03 | 127 | 32 | 2 | chr2q24 | |
| GeneFamily | PHD finger proteins | 1.72e-04 | 90 | 22 | 3 | 88 | |
| GeneFamily | Sterile alpha motif domain containing | 5.08e-03 | 88 | 22 | 2 | 760 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 8.53e-03 | 115 | 22 | 2 | 769 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.21e-05 | 199 | 32 | 4 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.24e-05 | 200 | 32 | 4 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.24e-05 | 200 | 32 | 4 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.24e-05 | 200 | 32 | 4 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.24e-05 | 200 | 32 | 4 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 138 | 32 | 3 | 321070b6900887b27da0f2b25808a05a8ab89ee7 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 138 | 32 | 3 | 19ffd66256fa94d728138d37d0a5a3bac7722dbb | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Rectal_Adenocarcinoma|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.31e-04 | 138 | 32 | 3 | e1e936ff4080bda2810c5fd1154a706359f377a5 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-04 | 148 | 32 | 3 | 80470353e12599440f711b6e107730763376d04d | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.81e-04 | 154 | 32 | 3 | ec920cae12ea1d14b6c973f6e903f895f80e3c50 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-04 | 167 | 32 | 3 | 8fede587572d465cb63f7828141a574185bbb819 | |
| ToppCell | 368C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.38e-04 | 169 | 32 | 3 | ea600c63cf9572bc4b3cad6392f67bd0d92c7fc9 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-04 | 170 | 32 | 3 | a121e10099faaeb60251eec162f38caf7c4238c2 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.51e-04 | 172 | 32 | 3 | 4483073469001770015526303772fd54906c5d68 | |
| ToppCell | Nasal_Brush-Epithelial-Basal_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.51e-04 | 172 | 32 | 3 | 58eaadf12366701103a0d1f133462c9495fedc30 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-04 | 174 | 32 | 3 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.64e-04 | 175 | 32 | 3 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 175 | 32 | 3 | f7cd2ef79d91d64976fcdb5f1e7343b24ba27456 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-04 | 177 | 32 | 3 | 291231b1520c135e92739e201495fe1935efa927 | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-04 | 177 | 32 | 3 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.78e-04 | 178 | 32 | 3 | 185b44700f06ec58b3c09c80520502166c965fd6 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.78e-04 | 178 | 32 | 3 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.82e-04 | 179 | 32 | 3 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.82e-04 | 179 | 32 | 3 | 9ba8693fba2175bca9ff9735cc04e657abeb9084 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.82e-04 | 179 | 32 | 3 | 56db12467b445f2b8ef92af50779eeab10413eb2 | |
| ToppCell | MS-Treg-naive_CD4|MS / Condition, Cell_class and T cell subcluster | 2.87e-04 | 180 | 32 | 3 | 7ca083616926d98420fa11a6e5ebc981623f79ac | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 2.91e-04 | 181 | 32 | 3 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.96e-04 | 182 | 32 | 3 | 3fddadb2ff75013ec6eeb415872667a6bae1da2d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.01e-04 | 183 | 32 | 3 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.11e-04 | 185 | 32 | 3 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.16e-04 | 186 | 32 | 3 | 6f88b68735d0f7c9904eb8413e6007910d556185 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.16e-04 | 186 | 32 | 3 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-04 | 187 | 32 | 3 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.21e-04 | 187 | 32 | 3 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.26e-04 | 188 | 32 | 3 | ee151792c7ac9afe820f1a281c6dab383799f358 | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.31e-04 | 189 | 32 | 3 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 3.31e-04 | 189 | 32 | 3 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-04 | 189 | 32 | 3 | 319e42f6e2322208de78bc666fb2c074707eb4da | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.36e-04 | 190 | 32 | 3 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.36e-04 | 190 | 32 | 3 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.41e-04 | 191 | 32 | 3 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.46e-04 | 192 | 32 | 3 | 1b228f0929b505de82a39bf64c837887b0e56701 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.46e-04 | 192 | 32 | 3 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.46e-04 | 192 | 32 | 3 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.46e-04 | 192 | 32 | 3 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.52e-04 | 193 | 32 | 3 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.52e-04 | 193 | 32 | 3 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.52e-04 | 193 | 32 | 3 | fe9720185929ef849edd1b8eb4854306b392e5a2 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-04 | 193 | 32 | 3 | a5695ce2e24a62026ae28f3dea07ca4a435206b8 | |
| ToppCell | RA|World / Chamber and Cluster_Paper | 3.57e-04 | 194 | 32 | 3 | 08f0afbb68a63150fbe107a5337299081c3f69e4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.57e-04 | 194 | 32 | 3 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.57e-04 | 194 | 32 | 3 | 7826fe5eb254ac032de0d978f39585a40e0b3ee4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-04 | 195 | 32 | 3 | 633c7668fe365f7b0f7851cdc442d5dd89c454e2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38|World / Primary Cells by Cluster | 3.68e-04 | 196 | 32 | 3 | 38da0751941adca650fe9b383d9f343153978eb5 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn|World / Primary Cells by Cluster | 3.68e-04 | 196 | 32 | 3 | 721650a08d260faf530dbd52d4e9275d27f3bac2 | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.68e-04 | 196 | 32 | 3 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | LPS_IL1RA_TNF|World / Treatment groups by lineage, cell group, cell type | 3.73e-04 | 197 | 32 | 3 | 0a6550dce156fc81f15b1e7830d331ca50d87d06 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.73e-04 | 197 | 32 | 3 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.73e-04 | 197 | 32 | 3 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.79e-04 | 198 | 32 | 3 | 72d91bd0c727ecadc41e023a16c9326158db1b7b | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-04 | 198 | 32 | 3 | 306e28d31fd587409a12dcccc6b2abd7dc9c2e0a | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-squamous_epithelial_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.79e-04 | 198 | 32 | 3 | 441608034c787e55691558a480dcd07e37419138 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.79e-04 | 198 | 32 | 3 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.79e-04 | 198 | 32 | 3 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_lymphatic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-04 | 198 | 32 | 3 | 05429f18e1d74880c1835568c86177f661b3477a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.90e-04 | 200 | 32 | 3 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.90e-04 | 200 | 32 | 3 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Mesenchymal-Mesoderm|5w / Sample Type, Dataset, Time_group, and Cell type. | 3.90e-04 | 200 | 32 | 3 | 0927061536a664b4f7feb9e5b0a8c11ca0d5955c | |
| ToppCell | LPS_IL1RA-Epithelial_airway-airway_epithelial-Airway-Club|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.90e-04 | 200 | 32 | 3 | df90b67490cd649de3e3a713762ffbc34a698899 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_only / Treatment groups by lineage, cell group, cell type | 3.90e-04 | 200 | 32 | 3 | a9ff3210127000b3dd9e97136163c98c2b0817d7 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.90e-04 | 200 | 32 | 3 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 3.90e-04 | 200 | 32 | 3 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.90e-04 | 200 | 32 | 3 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| Disease | ferritin measurement | 2.65e-04 | 119 | 31 | 3 | EFO_0004459 | |
| Disease | colorectal cancer (is_implicated_in) | 2.78e-04 | 121 | 31 | 3 | DOID:9256 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LKPVCYVAPSLCDTH | 376 | Q8NCV1 | |
| KHCHCSASYLPPDCS | 631 | Q99965 | |
| CHTYCHRPKITTIPD | 1956 | Q9UIF8 | |
| HHSSYQPLCLPLPVC | 506 | P49792 | |
| LLTHLYSHLKCSPLC | 311 | Q96DU7 | |
| ILHKRCSLPPSYCSK | 1231 | Q9NU22 | |
| VPSKCVQHYCHTSPT | 201 | Q6VAB6 | |
| KCLPFCHSNVLSHSY | 166 | Q8NH63 | |
| SQHCKSLAIPCPAHY | 496 | Q14332 | |
| CGLHKPEPYCIVSHL | 56 | P07942 | |
| VHTACKDLYHPICPL | 286 | Q86XP1 | |
| NHFYCDTPPLLKLSC | 181 | Q8NGF4 | |
| CKLHYHLGCLDPPLT | 746 | O94880 | |
| QHPKTHPESCSYCRL | 326 | Q86T90 | |
| PCLYKPHCHQSSLSR | 766 | Q5T0Z8 | |
| CNYPLAEHLTPTKHA | 356 | O95393 | |
| HEHYVTLNLPCCPLS | 1051 | Q96HP0 | |
| LCPLSCPPHSHYEAC | 1131 | Q9Y6R7 | |
| CPIGKEYLHSSHCSP | 276 | Q96GE4 | |
| CSRENCKYLHPPTHL | 61 | Q5VZF2 | |
| TCPSSYHIHCLNPPL | 466 | Q14839 | |
| LLCQPHSHSLVYVCK | 271 | Q9UBP4 | |
| CLHNLTAHCSPYCPL | 1991 | A2VEC9 | |
| SCGRHHCPHLPTKIY | 11 | Q8IYX7 | |
| HHSSYQPLCLPLPVC | 506 | P0DJD1 | |
| TCHYPLPAHLSKTLC | 186 | Q7Z443 | |
| HSSVRPYTCPHCPKA | 566 | Q96K58 | |
| APQPCCLHLYSHLTD | 521 | A6NE52 | |
| YICSCLHSGLTPHLT | 261 | O00329 | |
| HDKTPTHFCPLCDYS | 1251 | P52746 | |
| PHSPLKFHTYAVHCC | 46 | Q8N9V3 | |
| VHCLLPYCSLHLHLK | 516 | Q8WY21 | |
| PYCSLHLHLKVSENP | 521 | Q8WY21 |